company
as of 2026-07-01Luye Pharma Group Ltd.
at a glance
14 trials sponsored · 10 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
10 assets
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Paliperidone
drugsmall molecule
Risperidone
drugsmall molecule
LY03004
drugsmall molecule
LY03010
drugsmall molecule
LY03010 156 mg treatment group, deltoid
drugsmall molecule
LY03010 156 mg treatment group, gluteal
drugsmall molecule
LY03010 351 mg treatment group, deltoid
drugsmall molecule
LY03010 351 mg treatment group, gluteal
drugsmall molecule